Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective against non-small cell lung cancer (NSCLC) with activating EGFR mutations, but resistance is inevitable. Mechanisms of acquired resistance include T790M mutations and epithelial–mesenchymal transition (EMT). One...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuehong, Singh, Ratnakar, Wang, Liguang, Nilsson, Monique, Goonatilake, Ruchitha, Tong, Pan, Li, Lerong, Giri, Uma, Villalobos, Pamela, Mino, Barbara, Rodriguez-Canales, Jaime, Wistuba, Ignacio, Wang, Jing, Heymach, John V., Johnson, Faye M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216995/
https://www.ncbi.nlm.nih.gov/pubmed/27384992
http://dx.doi.org/10.18632/oncotarget.10332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216995/
https://www.ncbi.nlm.nih.gov/pubmed/27384992
http://dx.doi.org/10.18632/oncotarget.10332

Ejemplares similares